FDA Works with Partners to Establish Important Therapeutic Area Data Standards

Clarification, November 5, 2012: CFAST is a joint initiative of CDISC and the Critical Path Institute. The FDA and TransCelerate Biopharma, Inc. are partnering with CFAST in its Therapeutic Area Standards Program.

share
Facebook